2011
DOI: 10.1186/2045-824x-3-3
|View full text |Cite
|
Sign up to set email alerts
|

Nanotechnology-mediated targeting of tumor angiogenesis

Abstract: Angiogenesis is disregulated in many diseased states, most notably in cancer. An emerging strategy for the development of therapies targeting tumor-associated angiogenesis is to harness the potential of nanotechnology to improve the pharmacology of chemotherapeutics, including anti-angiogenic agents. Nanoparticles confer several advantages over that of free drugs, including their capability to carry high payloads of therapeutic agents, confer increased half-life and reduced toxicity to the drugs, and provide m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
70
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(71 citation statements)
references
References 101 publications
1
70
0
Order By: Relevance
“…Our findings have profound implications for targeting the endothelial-specific expression of β3-integrin to inhibit tumor angiogenesis, a strategy that is growing in popularity with the maturation of nanotechnology. 38 Consistent with our findings in β3-knockout animals, 10 the depletion of endothelial β3-integrin did not alter the structure of established tumor vessels (Online Figure IA and Online Figure VIA). Sprouting angiogenesis involves an initial increase in EC proliferation, migration, and tube formation, followed by maturation of vessels that includes the recruitment of supporting cells and the deposition of an intact basement.…”
Section: Discussionsupporting
confidence: 80%
“…Our findings have profound implications for targeting the endothelial-specific expression of β3-integrin to inhibit tumor angiogenesis, a strategy that is growing in popularity with the maturation of nanotechnology. 38 Consistent with our findings in β3-knockout animals, 10 the depletion of endothelial β3-integrin did not alter the structure of established tumor vessels (Online Figure IA and Online Figure VIA). Sprouting angiogenesis involves an initial increase in EC proliferation, migration, and tube formation, followed by maturation of vessels that includes the recruitment of supporting cells and the deposition of an intact basement.…”
Section: Discussionsupporting
confidence: 80%
“…Such a modification increases the targeting potential of dendrimers toward cancer cells [70]. A combination of imaging modalities and several biocompatible and biodegradable dendrimers over the decade has been used to develop bio-imaging probes that have prolonged plasma half-lives, enhanced stability, reduced toxicity and improved target specificity.…”
Section: Molecular Imaging With Radiolabeled Dendrimersmentioning
confidence: 99%
“…[1][2][3][4][5][6][7][8] Carbon nanotubes (CNTs), with their unique physical and chemical properties, hold great promise for drug delivery and cancer therapy. 9 The research mechanisms of selective tumor targeting with biofunctionalized CNTs are currently being intensely explored due to their impressive ability to convert near-infrared (NIR) laser radiation into heat.…”
Section: Introductionmentioning
confidence: 99%